Ultrasound Imaging of the Larynx and Diaphragm During NIV and Cough Assist

January 30, 2023 updated by: Haukeland University Hospital

Can Ultrasound Imaging of Both Upper Airways and Diaphragm be Used to Guide Efficacy on Non-invasive Ventilation and Cough Assist

The study examines if diagnostic ultrasound imaging of larynx and diaphragm can be as accurate as transnasal fiberoptic laryngoscopy in visualizing the larynx during NIV and Mechanically Assisted Cough interventions.

Study Overview

Detailed Description

Transnasal fiberoptic laryngoscopy (TFL) is gold standard for visualising the larynx. TFL has been used to visualize the laryngeal response patterns during non-invasive therapeutic interventions, as during Mechanically Assisted Cough in patients with Amyotrophic Lateral Sclerosis. The examinations revealed that the larynx adducted during the application of positive pressures, which restricted the airflow and reduced the efficacy of the treatment. The higher treatment pressures resulted in ineffective interventions as a result of the adducted vocal cords obstructing flow. This knowledge has changed the treatment approach for patients with possible upper airway instability by individualizing the treatment pressures and flow due to laryngeal responses.

TFL may cause slight discomfort when placing the laryngoscope. Diagnostic ultrasound is non-invasive easily applicable technique that has gained increasing popularity in diagnosing cardiopulmonary and laryngeal conditions during the recent times. The aim of the study is to investigate whether the diagnostic ultrasound of the larynx can be as accurate as TFL during Mechanically Assisted Cough and Non-Invasive Ventilation (NIV). The present study will include healthy participants. Hypothesis is that diagnostic ultrasound of larynx can provide clinical valuable information of the laryngeal response patterns during Mechanically Assisted Cough and NIV.

The aims of the study are:

  • To evaluate the feasibility of diagnostic ultrasound imaging of the larynx, and to compare to the gold standard of TFL used during ongoing NIV and Mechanically Assisted Cough in healthy subjects.
  • To evaluate the feasibility of ultrasound imaging if the diaphragm during ongoing NIV and Mechanically Assisted Cough in healthy subjects.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vestlandet
      • Bergen, Vestlandet, Norway, 5021
        • Haukeland University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers will be recruited among Healthcare Professionals and medical- and physiotherapy students

Description

Inclusion Criteria:

  • Healthy subjects

Exclusion Criteria:

  • history of laryngospasm or pneumothorax

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy persons
Noninvasive ventilation and Cough Assist
To investigate if Ultrasound imaging can visualize the larynx during NIV and Cough Assist, and be as accurate as laryngoscopy
To investigate if Ultrasound imaging can visualize the larynx during NIV and Cough Assist, and be as accurate as laryngoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opening movements in larynx on transnasal fiberoptic laryngoscopy (TFL) during inspiration
Time Frame: Day 1
Number of participants.
Day 1
Obstructive movements in larynx on TFL during inspiration
Time Frame: Day 1
Number of participants.
Day 1
Closure in larynx on TFL during the compression phase of cough
Time Frame: Day 1
Number of participants.
Day 1
Opening movements in larynx on TFL during expiration
Time Frame: Day 1
Number of participants.
Day 1
Narrower movements in larynx on TFL during expiration
Time Frame: Day 1
Number of participants.
Day 1
Obstructive movements in larynx on TFL during expiration
Time Frame: Day 1
Number of participants.
Day 1
Opening movements in larynx on Anterior Ultrasound (USA) during inspiration
Time Frame: Day 1
Number of participants.
Day 1
Obstructive movements in larynx on USA during inspiration
Time Frame: Day 1
Number of participants.
Day 1
Closure in larynx on USA during the compression phase of cough
Time Frame: Day 1
Number of participants.
Day 1
Opening movements in larynx on USA during expiration
Time Frame: Day 1
Number of participants.
Day 1
Narrower movements in larynx on USA during expiration
Time Frame: Day 1
Number of participants.
Day 1
Obstructive movements in larynx on USA during expiration
Time Frame: Day 1
Number of participants.
Day 1
Opening movements in larynx on Lateral Ultrasound (USL) during inspiration
Time Frame: Day 1
Number of participants.
Day 1
Obstructive movements in larynx on USL during inspiration
Time Frame: Day 1
Number of participants.
Day 1
Closure in larynx on USL during the compression phase of cough
Time Frame: Day 1
Number of participants.
Day 1
Opening movements in larynx on USL during expiration
Time Frame: Day 1
Number of participants.
Day 1
Narrower movements in larynx on USL during expiration
Time Frame: Day 1
Number of participants.
Day 1
Obstructive movements in larynx on USL during expiration
Time Frame: Day 1
Number of participants.
Day 1
Comparison of observed movements in the larynx on transnasal fiberoptic laryngoscopy (TFL) and Anterior Ultrasound (USA) imaging.
Time Frame: Day 1
The chi-square test will assess differences between examination methods.
Day 1
Comparison of observed movements in the larynx on transnasal fiberoptic laryngoscopy (TFL) and Lateral Ultrasound (USL) imaging.
Time Frame: Day 1
The chi-square test will assess differences between examination methods.
Day 1
Comparison of observed movements in the larynx on Anterior Ultrasound (USA) and Lateral Ultrasound (USL) imaging.
Time Frame: Day 1
The chi-square test will assess differences between examination methods.
Day 1
Ultrasound imaging of diaphragm excursion
Time Frame: Day 1
Measurements will be performed in quiet breathing, NIV and Cough Assist. Diaphragm excursions are recorded in M-mode, and will be presented in millimeters.
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjects perception of the examination with TFL - VAS scale
Time Frame: Day 1
Participant's experience of the examination will be evaluated on a Visual Analog Scale (VAS) from 0-10 where higher number indicate more discomfort.
Day 1
Subjects perception of the examination with Laryngeal ultrasound - VAS scale
Time Frame: Day 1
Participant's experience of the examination will be evaluated on a Visual Analog Scale (VAS) from 0-10 where higher number indicate more discomfort.
Day 1
Airflow registration
Time Frame: Day 1
A pneumotachograph inserted in the Circuit between the facemask and the therapeutic device will register airflow during the interventions. Interruptions of the airflow will verify the possible laryngeal adductions.
Day 1
Pressure registration
Time Frame: Day 1
A pressure transducer inserted in the Circuit between the facemask and the therapeutic device measures the pressure and verify the settings of the NIV and Mechanically assisted Cough.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tiina M Andersen, PhD, Haukeland University Hospital
  • Study Chair: George Ntoumenopoulos, PhD, St Vincent's Hospital, Sydney
  • Study Chair: Maria Vollsæter, PhD, Haukeland University Hospital
  • Study Chair: Anne Kristine Brekka, MSc, Sorlandet Hospital HF
  • Study Chair: Ola D Røksund, Professor, Bergen University College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

April 7, 2022

Study Completion (Actual)

April 7, 2022

Study Registration Dates

First Submitted

July 27, 2020

First Submitted That Met QC Criteria

October 9, 2020

First Posted (Actual)

October 14, 2020

Study Record Updates

Last Update Posted (Actual)

January 31, 2023

Last Update Submitted That Met QC Criteria

January 30, 2023

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Persons

Clinical Trials on Diagnostic Ultrasound

3
Subscribe